Abiopharma

🔍 Biles Linda M (Executive)

Company: M-tron Industries, Inc. (MPTI)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 1,218 shares of Common Stock at $85.05 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 28,723.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 10,000 shares of Stock Option (right to buy) at $40.32 per share (Derivative)
  Date: 2026-08-11 | Code: H | Expires: 2030-04-04 | Exercise: 2026-04-04 | shares_owned_after: 10,000.00 | Footnotes: F3

Footnotes:

• F1: Represents shares sold to cover tax withholding obligations in connection with the vesting of a restricted stock award.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.62 to $85.44, inclusive. The shares were sold pursuant to Rule 144 under the Securities Act of 1933, as amended, and a Form 144 was filed in connection with such sale. The reporting person undertakes to provide to the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: Stock options of the Issuer vesting as follows: 30% on 4/4/2026, 30% on 4/4/2027, and 40% on 4/4/2028.